Literature DB >> 11802174

Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.

Eri Arikawa-Hirasawa1, Susana G Rossi, Richard L Rotundo, Yoshihiko Yamada.   

Abstract

The collagen-tailed form of acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular junction (NMJ), where it is responsible for rapidly terminating neurotransmission. This unique oligomeric form of AChE, consisting of three tetramers covalently attached to a collagen-like tail, is more highly expressed in innervated regions of skeletal muscle fibers, where it is externalized and attached to the synaptic basal lamina interposed between the nerve terminal and the receptor-rich postsynaptic membrane. Although it is clear that the enzyme is preferentially synthesized in regions of muscle contacted by the motoneuron, the molecular events underlying its localization to the NMJ are not known. Here we show that perlecan, a multifunctional heparan sulfate proteoglycan concentrated at the NMJ, is the unique acceptor molecule for collagen-tailed AChE at sites of nerve-muscle contact and is the principal mechanism for localizing AChE to the synaptic basal lamina.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802174     DOI: 10.1038/nn801

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  46 in total

Review 1.  Extracellular matrix: functions in the nervous system.

Authors:  Claudia S Barros; Santos J Franco; Ulrich Müller
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Cell type-specific requirements for heparan sulfate biosynthesis at the Drosophila neuromuscular junction: effects on synapse function, membrane trafficking, and mitochondrial localization.

Authors:  Yi Ren; Catherine A Kirkpatrick; Joel M Rawson; Mu Sun; Scott B Selleck
Journal:  J Neurosci       Date:  2009-07-01       Impact factor: 6.167

Review 3.  To build a synapse: signaling pathways in neuromuscular junction assembly.

Authors:  Haitao Wu; Wen C Xiong; Lin Mei
Journal:  Development       Date:  2010-04       Impact factor: 6.868

Review 4.  Diverse roles for glycosaminoglycans in neural patterning.

Authors:  Kristian Saied-Santiago; Hannes E Bülow
Journal:  Dev Dyn       Date:  2017-08-30       Impact factor: 3.780

5.  Contributions of rapid neuromuscular transmission to the fine control of acoustic parameters of birdsong.

Authors:  Caitlin Mencio; Balagurunathan Kuberan; Franz Goller
Journal:  J Neurophysiol       Date:  2016-11-16       Impact factor: 2.714

Review 6.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

7.  Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.

Authors:  Mikako Ito; Yumi Suzuki; Takashi Okada; Takayasu Fukudome; Toshiro Yoshimura; Akio Masuda; Shin'ichi Takeda; Eric Krejci; Kinji Ohno
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

8.  COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.

Authors:  Juan Arredondo; Marian Lara; Fiona Ng; Danielle A Gochez; Diana C Lee; Stephanie P Logia; Joanna Nguyen; Ricardo A Maselli
Journal:  Hum Genet       Date:  2013-11-27       Impact factor: 4.132

Review 9.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  Perlecan is required for FGF-2 signaling in the neural stem cell niche.

Authors:  Aurelien Kerever; Frederic Mercier; Risa Nonaka; Susana de Vega; Yuka Oda; Bernard Zalc; Yohei Okada; Nobutaka Hattori; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Stem Cell Res       Date:  2013-12-28       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.